Cristina Conforti Andreoni, PhD profile page

Dr. Cristina Conforti Andreoni obtained her PhD in Translational Medicine at the University of Milan-Bicocca, Italy, in collaboration with SIgN, A-STAR Singapore, researching the dendritic cell response to danger signals. After a post-doctoral fellowship on the same project and her role as a Scientific Officer at the biotech startup Ayoxxa at National University of Singapore, she joined Miltenyi Biotec in Bergisch Gladbach, Germany as Global Product Manager for Cell Culture. In 2018, she took over the Group Leader position of the Translational Immunology Team with focus on myeloid cells, B cells, and NK cells. And since 2023, she is the Portfolio Strategy Manager for Immunotherapy.